Lunit INSIGHT DBT

FDA & CE | Breast | DBT | Amplifier Partner

Amplifier Marketplace Radiology

Description of use

Lunit INSIGHT DBT is a computer-assisted detection and diagnosis (CADe/x) software intended to be used concurrently by interpreting physicians to aid in the detection and characterization of suspicious lesions for breast cancer in digital breast tomosynthesis (DBT) exams. Through the analysis, the regions of soft tissue lesions and calcifications are marked with an abnormality score indicating the likelihood of the presence of malignancy for each lesion as well as for each breast.

The product is intended for use in screening digital breast tomosynthesis images to identify and characterize suspicious areas for breast cancer for interpreting physicians’ review.

How is the application integrated?

  • Can the end-user read the results in IDS7: Yes
  • DICOM output: DICOM SC, DICOM SR
  • CAD findings as image overlay: Yes
  • Worklist integration: Yes
  • Pre-populated reports: Yes

Ask your Sectra representative which version of the Sectra PACS is compatible with the highlighted integration standards.

Contact us

Referring articles

The below are peer-reviewed articles that have been submitted by the AI vendor to serve as scientific validation of the application.

Other applications by this vendor

Lunit INSIGHT CXR
CE | X-ray
AI-powered, automated detection of 10 radiologic findings on chest x-ray images with 97-99% accuracy, leading to a 20% increase in reading accuracy and a 65% reduction in reading time for normal cases.
Lunit INSIGHT MMG
FDA, CE & Health Canada | FFDM
AI-powered, automated detection of breast cancer on mammograms with 96% accuracy, leading to a 14% reduction in false positive recall rate and a 18% increase in reading accuracy.

Let’s talk

Are you interested in learning more? Please do not hesitate to get in touch with us at Sectra.

Contact us

The application content is provided by the respective AI vendors.